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Various attempts have been made to delineate “specific clinical features” that occur 
with DST nonsuppression. Carroll et al. (1976) and Schlesser et al. (1979) failed to find 
any manifestations that convincingly distinguished nonsuppressors from suppressors. Wi- 
nokur et al. (1978) and Lewis and Winokur (1983) reported that nonsuppression was 
more frequently associated with distinct genetic subtypes of depression, but others have 
challenged this finding (Carroll et al. 1980; Rudorfer et al. 1982). Reus (1982) suggested 
that nonsuppressors have more “classical endogenous signs of dysfunction” on admission, 
and more subjective complaints than suppressors. Nasr et al. (1983) also found that the 
DST discriminated between clinical subtypes. 
A major problem in most prior reports is that associations between DST nonsuppression 
and endogeneity have been evaluated only in dichotomous subgroups, e.g., DST sup- 
pressors versus nonsuppressors or endogenous versus nonendogenous depressives. Un- 
fortunately, considerable information is lost when categorical analyses constitute the sole 
approach; relationships between absolute hypothalamic-pituitary-adrenal (HPA) values 
and severity or degree of endogeneity may be missed. 
To help clarify this somewhat controversial question, we examined the relationship 
between endogeneity and absolute postdexamethasone plasma cortisol levels. We hy- 
pothesized that as the absolute severity of the depressive syndrome and/or the number of 
endogenous symptoms increased, DST cortisol levels also would increase. 
Methods 
Subjects 
Our sample consisted of 73 patients hospitalized in the Clinical Studies Unit (CSU) for 
Affective Disorders at the University of Michigan during 1979-1984. Each individual 
was evaluated with the standard CSU protocol: (1) a IO-14-day drug washout period, 
(2) comprehensive medical and neurological examination, (3) differential, absolute blood 
counts, thyroid studies, B12 and folate levels, and VDRL, (4) electrocardiogram (EKG), 
electroencephalogram (EEG), chest and skull x-ray, (5) at least two independent, un- 
structured clinical evaluations by CSU psychiatrists, (6) a structured assessment by a 
trained interviewer using the Schedule for Affective Disorders and Schizophrenia (SADS) 
(Spitzer and Endicott 1975), (7) a family interview whenever feasible to confirm family 
history and longitudinal course, and (8) a review of prior medical records if available. 
At completion of these data collections, a consensus diagnosis was formulated using 
Research Diagnostic Criteria (RDC) (Spitzer et al. 1977). All patients were diagnosed 
as having major depressive disorder (MDD) using RDC. Clinical and demographic char- 
acteristics of the patient sample are shown in Table 1. 
Operational Dejinitions of Endogeneity 
Because a primary objective was to determine if DST values reflected degree of endo- 
geneity, it was essential to have close temporal linkage between DSTs and measures of 
endogeneity. To accomplish this, we selected the DST from the time period immediately 
prior to treatment (10-14 days drug-free), thus controlling for sources of variance due 
to treatment. SADS interviews were not always conducted at the exact time when the 
drug-free DST was performed, but the Hamilton Rating Scale for Depression (HRSD) 
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the degree of endogeneity, we developed an o~rationa1 index of “endogeneity” to match 
the endogeneity items from the RDC. The comparisons are illustrated in Table 2. The 
index was compiled using the Hamilton Rating Scale for Depression (Hamilton 1960) 
and the CSU Current Status form (this is a clinical questionnaire that clinicians on the 
unit complete on a weekly basis). Using this index, it was possible to compare postdex- 
amethasone cortisof values and endogeneity at the same time point. We then divided 
subjects into three categories, based on the number of endogenous items they manifested, 
i.e., nonendogenous (O-3 items), probable endogenous (4-6 items), and definite endog- 
enous (6 items and more). We thus developed measures of both categorical endogenous 
groups and actual degree of endogeneity (based on the number of endogenous symptoms). 
In compiling our “endogeneity” index and classifying patients into the three categories 
described above, we paid primary attention to the absolute number of endogenous symp- 
toms. Groupings of symptoms (e.g., Group A versus Group B in RDC) were neither 
considered mandatory nor were they given any extra significance. 
Clinical raters in the CSU always are blind to DST results. 
We used our previously standardized approach for the DST (Carroll et al. 198 1). All 
patients received 1 mg of oral dexamethasone at 11:OO PM, and plasma samples were 
collected the following day at 4:00 PM and 1 I:00 PM. Plasma cortisol concentrations were 
assayed using a modification of Murphy’s competitive protein binding technique (Murphy, 
1967). Our intraassay coefficient of variance is 6.5% and interassay coefficient of variation 
is 9%. In the CSU, a cortisol value >5 pgidl is considered to be “nonsuppression.” This 
cut-off value was established in our setting only after comparisons of endogenous de- 
pressives, psychiatric controls, and normal controls. In our studies, the maximum cortisol 
level from either the 4:00 PM or 11:OO PM samples was used as the indicator of HPA 
dysregulation. This value should not be adopted indiscriminately in other settings. 
Table 2. 
RDC-Endogenous signs and symptoms 
Operational Index of Endogeneity 
(compiled from the Hamilton Rating 
Scale for depression and the 
Current Status questionnaire) 
At least four symptoms are required for probable and 
six for definite, with at least one symptom from Group 
A. 
Group A 
(1) Distinct quality to depressed mood 
(2) Lack of reactivity to environmental changes 
(3) Mood is regularly worse in the morning 
Group B 
(1) Depressed mood 
(2) Loss of reactivity 
(3) Diurnal mood change 
(4) Feelings of self-reproach or excessive or 
inappropriate guilt 
(5) Psychomotor retardation or agitation 
(6) Poor appetite 
(7) Weight loss 
(8) Loss of interest or pIeasure in usual activities or 
decreased sexual drive 
(4) Guilt feelings 
(5) Retardation and agitation 
(6) Decreased sexual interest and loss of appetite 
(7) Weight loss 
(8) Loss of pleasure 
(9) Early morning awakening or middle insomnia (9) Middle and delayed insomnia 
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I‘he DST was repeated weekly. For this report. we used DST values immediately prior 
to treatment, following IO-14 days of drug washout. Maximum postdexamethasone plasma 
cortisol concentration (at 4:00 F’~I or I I:00 PM) and nonsuppression versus suppression 
were used as continuous and dichotomous DST variables, respectively. 
To improve normality of distribution and equality of variance, we log-transformed plasma 
dexamethasone concentrations prior to any statistical analyses. To compare subgroups 
on categorical dimensions, we used the (x’) test and the maximum likelihood estimate 
(MLE) (for tables larger than 7 x 2 with 0 cells). The one-way Analysis of Variance 
(ANOVA) was employed for analyses of differences among levels of endogeneity. A 
one-way Analysis of Covariance model (ANCOVA), with weight and age as covariates. 
also was used. 
Results 
There was a statistically significant relationship (Y = 0.27.1~ = 0.02) between maximum 
postdexamethasone cortisol level and the degree of endogeneity (Figure 1). Consistent 
with this correlation. when the three categorical endogenous subgroups (non, probable. 
and definite) were examined, the percentage of nonsuppressors increased with endogeneity 
from 0% for the nonendogenous to 52% for the probable endogenous, to 61% for the 
definite endogenous (Table 3). The mean of maximum cortisol in each of the three 
subgroups also increased with endogeneity (Table 3). These observations establish a link 
between degree of endogeneity and postdexamethasone plasma levels. Thus, our hy- 
pothesis was supported. given the constraints placed on it by the small size (II = 4) 01 
our nonendogenous group. 
When we evaluated severity relationships with DST values, we found that DST values 
were even more strongly correlated with severity of depression (as demonstrated by HRSD 
scores) (I’ = 0.35. I) = 0.000) than they were with degree ofendogeneity (see Figure 2). 
Figure I. The relationship between the number of endogenous sympoms (KDC) and the mean 
postdexamethasone plasma cortisol lcvcl (@dl). The relationship is a positive one. As the number 
of endogenous symptoms increases, the postdexamethasone plasma cortisol level increase\ (I- -I 0.27 
p 0.02). In parentheses are the numbers of subjects in each group. 
NUMBER OF ENDOGENOUS SYMPTOMS 
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Table 3. Relationship of Categorical Endogenous Groups with Postdexamethasone Plasma 







“F = 4.56, p = 0.01. 












We then evaluated the associations between “endogeneity” as described in the RDC 
and total HRSD items and found a significant correlation (r = 0.68, p = 0.000). Thus, 
endogeneity per se is highly confounded with severity of depression. Indeed, the items 
on the HRSD that we did not consider to be conventionally “endogenous” also correlated 
significantly with postdexamethasone cortisol levels (r = 0.49, p = 0.000). 
The two endogenous and the nonendogenous subgroups did not differ significantly in 
terms of gender distribution, proportion of unipolar to bipolar, number of previous epi- 
sodes, or presence of delusions (Table 1). 
Age and weight loss have been reported to confound the relationship between DST 
and severity. One-way ANOVA revealed that patients who were definitely endogenous 
were older and reported greater weight loss (HRSD item 17) in this episode (Table 1). 
However, a one-way ANCOVA model, testing for the effect of group membership (en- 
dogeneity) on DST and treating age and weight loss as covariates, showed that this effect 
was not influenced by the covariates. When absolute weight was a covariate, however, 
we found that although a significant relationship existed between DST and this covariate 
(F = 11.96, p < O.OOl), group membership continued to have a significant effect in the 
prediction of DST (F = 4.49, p = 0.01). Thus, endogeneity remained a significant 
predictor of DST when absolute weight was held constant. 
(18) 
HRSD SCORES (N in parentheses) 
Figure 2. The relationship of the 
overall severity of depression as es- 
timated by the Hamilton Rating Scale 
for Depression scores and the mean 
postdexamethasone plasma cortisol 
level (Fg/dl). Subjects were divided 
into six categories based on their 
HRSD scores (each category signi- 
fying a range of the HRSD scores). 
The relationship of severity to post- 
dexamethasone plasma cortisol 
levels is statistically significant 
(r = 0.45, p = 0.000). The num- 
ber of subjects in each category is in 
parentheses. 
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Discussion 
These data indicate that postdexamethasone plasma cortisol concentrations moderateI> 
reflect the degree of endogeneity. regardless of whether endogeneity is considered J 
continuous or a dichotomous variable. However, this correlation is not specific for “en- 
dogeneity” per se; DST values appear to reflect total severity of depression (HRSD total I 
even more strongly than endogeneity. 
This relationship between severity of depression and the DST has received only sporadic 
attention. and most reports dealing with this question have considered DST results cat- 
egorically, i.e.. suppressors versus nonsuppressors. Carroll et al. ( 1968) initially reported 
an association between severity of depression and resistance to dexamethasone suppres- 
sion. but in later reports Carroll and colleagues failed to contirm this relationship (Carroll 
and Davis 1970. Carroll et al. 1981). Brown et al. (1979) and Stokes et al. i 1975) found 
that DST nonsuppressors were more severely depressed than suppressors. Davis et al 
( I981 ) also noted that HRSD severity scores correlated positively and significantly with 
postdexamethasone cortisol concentrations; in contrast, predexamethasone baseline cor- 
tisol levels did not correlate with severity of depression. Brown and Shuey ( 1980) sug 
gested that nonsuppressors have greater cognitive impairment than suppressors, based on 
their inability to complete self-rating forms. but these authors felt that suppressors and 
nonsuppressors did not differ significantly in severity of depression as measured by HRSD 
scores. Brown and Qualls ( IO8 I ) also contended that nonsuppressors and suppressors did 
not differ in either severity or symptomatology. Thus, there are conflicting viewpoint\ 
concerning this issue when DST values are considered only categorically 
Few studies have analyzed DST cortisol levels on a continuum, such as described 111 
this report. Reus (1982) showed that patients with high levels of predexamethasone 8:(H) 
AM cortisol were more symptomatic on admission than those with normal levels, partic 
ularly in areas of anxiety and somatic concerns. Starkman and Schteingart ( 1981) studied 
patients with Cushing’s syndrome and observed a statistically significant relationship 
between the overall neuropsychiatric disability score and the degree of cortisol elevation 
whether measured by cortisol secretion rate. urinary free cortisol. or plasma cortisol. at 
X:00 AM. They also suggested that the relative proportion of cortisol to adrencorticotrophin 
hormone (ACTH), rather than the level of either hormone itself. seemed to be related 
most closely to severity of “depressed mood.” Feinberg and Carroll (1984i agreed that 
the 4:(H) PM sample of plasma cortisol correlated significantly with HRSD scores. Thus. 
there is a growing concensus that absolute DST values do reflect severity of depression 
Recent weight loss has been suggested to alter hypothalamic-pituitary-adrenal functiort 
(Berger et al. 1982; Edelstein et al. 1983). Feinberg and Carroll (1984) demonstrated 
that weight loss is highly confounded with total severity and age. This is predictable, 01 
course, because weight and appetite changes are integral components of major depression. 
Our data suggest that absolute weight may be as important a predictor of DST as reported 
weight loss per se, perhaps because the latter is so unreliable. 
In addition to confirming previously reported relationships between DST values and 
endogeneity , these data dramatize several aspects of endogeneity First, it may be essential 
to consider endogeneity on a continuum, as well as categorically. Although clinicianx 
are inclined to consider many clinical concepts as “present” or “not present,” “end{) 
geneity” more accurately may reflect a continuous degree of limbic pathophysiology. 
manifesting itself in increasing disturbances of reward reinforcement (anhedonia; loss (1% 
reactivity). sleep (initial. middle. or late insomnia; hypersomnia). psychomotor agitaticlrl 
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or ret~dation; loss of, decreases in, or increases in libido, appetite (and thus weight 
changes), and chronobiological dysrythmias (diurnal mood variation). The DST, which 
is also regulated by the same limbic-hypothalamic regulatory regions, appears to parallel 
this severity of endogenous/limbic dysregulation. 
Our data also confirm that endogeneity is confounded with total severity of depression. 
Even clinical items not ~aditionally considered to be “endogenous” are correlated with 
endogeneity. Caution is required in inte~reting some of our data, given the small pop- 
ulation of the nonendogenous group. These data suggest that considerable information is 
lost when clinical profiles are only considered dichotomously. 
We thank Pamela FIegel, Senior Research Associate, and the nursing staff on the Clinical Studies Unit for 
their assistance in conducting this study. 
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